Metrics as of 10/17/2026, 06:56 AM (Berlin time), refresh in progress.
Avantor Stock
Avantor, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Emmanuel Ligner
- Employees
- 13,500
- Market cap
- $11.1 B
- IPO
- 17/05/2019
Avantor, Inc. is a global provider of vital products and specialized services based in Radnor, USA. Established in 1904, the company operates across the Americas, Europe, Asia, the Middle East, and Africa. Its diverse customer base includes industries such as biopharmaceuticals, healthcare, educational institutions,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Avantor stock: price history
1D
+2.1%
1W
+4.8%
1M
+5.2%
6M
+92.7%
YTD
+43.3%
1Y
+12.7%
2Y
-33.8%
5Y
-57.2%
10Y
–
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~79% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vrange-breakout-v1.0 on 16/10/26. Not a buy or sell signal.Beta
What does this mean?
Range breakout
BullishThe price has broken out of a longer sideways range (support and resistance) to the upside or downside. In technical analysis, this is read as a signal that a new trend is starting in the breakout direction.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Avantor stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
Avantor, Inc. is a global provider of essential products and services for industries including biopharmaceuticals, healthcare, and high technology. Its portfolio comprises high-purity chemicals, laboratory consumables, single-use components, and specialized process materials as well as complex analytical instruments and laboratory furniture. The business model is complemented by services ranging from maintenance of technical equipment and on-site support at production facilities to assistance with scaling biopharmaceutical processes. Through the combination of necessary consumables for research and production along with specialized technical service, the company is deeply integrated into its customers' value chains.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Switching costs
- Capital intensity
- Medium
- Customer concentration
- Unknown
Ask the agents about Avantor
Analyst assessment of Avantor
PRICE TARGET LOW
US$7.00
CONSENSUS
US$12.25
MEDIAN
US$13.00
PRICE TARGET HIGH
US$16.00
0
STRONG BUY
8
BUY
16
HOLD
2
SELL
0
STRONG SELL
26
TOTAL · Hold
As of: 13/10/2026
Avantor stock metrics
P/E
-19.58
P/B
1.97
EV/EBITDA
115.7
RETURN ON EQUITY
0.7%
NET MARGIN
2.3%
DEBT/EQUITY
0.66
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
97.3%
FLOAT SHARES
657,806,317
AVG. DAILY VOLUME (30D)
9,192,068
Insider transactions (SEC)
Garner Todd W
Ligner Emmanuel
Hankamer Brittany
Eck Steven W
Sokenu Claudius
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.1%
Forums (Reddit)
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Avantor stock
What does Avantor do?
Avantor, Inc. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Emmanuel Ligner, the company employs around 13,500 people.
The IPO was on 17/05/2019; the stock trades on NYSE under the ticker AVTR.
What do analysts say about Avantor stock?
26 analysts rate the stock, the consensus is Hold (as of 13/10/2026).
The average price target is US$12.25, ranging from US$7.00 to US$16.00, with a median of US$13.00.
This is an external assessment, not a statement by Market Jury.
When does Avantor report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 79% stronger than usual.
Does Avantor pay a dividend?
No, Avantor currently does not pay a dividend.
Which stocks are comparable to Avantor?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies and Repligen.
How can I get Avantor stock analyzed?
Clicking "Analyze stock" lets five strategies assess Avantor against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.